[Noradrenergic afferents modulation of tyrosine hydroxylase expression in rat supraoptic nucleus vasopressinergic neuron during ontogenesis. ].
Abramova
M A
MA
Ugriumov
M V
MV
Calas
A
A
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000818:Animals; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D008297:Male; D009474:Neurons / Q000201:enzymology; D009995:Osmosis / Q000187:drug effects; D011224:Prazosin / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D013495:Supraoptic Nucleus / Q000196:embryology / Q000201:enzymology*; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis*
D000317:Adrenergic alpha-Antagonists; D014446:Tyrosine 3-Monooxygenase; D011224:Prazosin